Forsgren Mikael Fredrik, Dahlqvist Leinhard Olof, Dahlström Nils, Cedersund Gunnar, Lundberg Peter
Wolfram MathCore AB, Linköping, Sweden, and Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden; Department of Radiation Physics and Division of Radiological Sciences, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Department of Radiation Physics and Division of Radiological Sciences, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.
PLoS One. 2014 Apr 18;9(4):e95700. doi: 10.1371/journal.pone.0095700. eCollection 2014.
Diffuse liver disease (DLD), such as non-alcoholic fatty liver disease (NASH) and cirrhosis, is a rapidly growing problem throughout the Westernized world. Magnetic resonance imaging (MRI), based on uptake of the hepatocyte-specific contrast agent (CA) Gd-EOB-DTPA, is a promising non-invasive approach for diagnosing DLD. However, to fully utilize the potential of such dynamic measurements for clinical or research purposes, more advanced methods for data analysis are required.
A mathematical model that can be used for such data-analysis was developed. Data was obtained from healthy human subjects using a clinical protocol with high spatial resolution. The model is based on ordinary differential equations and goes beyond local diffusion modeling, taking into account the complete system accessible to the CA.
The presented model can describe the data accurately, which was confirmed using chi-square statistics. Furthermore, the model is minimal and identifiable, meaning that all parameters were determined with small degree of uncertainty. The model was also validated using independent data.
We have developed a novel approach for determining previously undescribed physiological hepatic parameters in humans, associated with CA transport across the liver. The method has a potential for assessing regional liver function in clinical examinations of patients that are suffering of DLD and compromised hepatic function.
弥漫性肝病(DLD),如非酒精性脂肪性肝病(NASH)和肝硬化,在整个西方世界正迅速成为一个日益严重的问题。基于肝细胞特异性造影剂(CA)钆塞酸二钠(Gd-EOB-DTPA)摄取的磁共振成像(MRI)是一种很有前景的诊断DLD的非侵入性方法。然而,为了将这种动态测量的潜力充分用于临床或研究目的,需要更先进的数据分析方法。
开发了一种可用于此类数据分析的数学模型。使用具有高空间分辨率的临床方案从健康人体受试者获取数据。该模型基于常微分方程,超越了局部扩散建模,考虑了CA可及的完整系统。
所提出的模型能够准确描述数据,这通过卡方统计得到了证实。此外,该模型是最小化且可识别的,这意味着所有参数的确定具有较小的不确定性。该模型也使用独立数据进行了验证。
我们开发了一种新方法,用于确定人类以前未描述的与CA在肝脏中转运相关的生理肝脏参数。该方法在对患有DLD和肝功能受损的患者进行临床检查时具有评估局部肝功能的潜力。